Promoter and Institution shareholding unchanged, indicating a lack of confidence from smart money.

Public shareholding has increased, suggesting retail investors may be reacting to market trends rather than informed decisions.

Sector averages show no changes in shareholding patterns, reinforcing the lack of conviction across the Pharma sector.